Newsroom
Filters: Biosimilar medicines
x
in-the-newsx
Can the European Union bring eye-wateringly expensive medicines to the […]
Read moreOpen
Read more“Digitalisation the key to efficient EU pharmaceutical regulation and easing […]
Read moreGenerics And Biosimilars Must Become A Central Policy Pillar, Says […]
Read more“EU Industry Welcomes New Schengen Strategy’s Green Lanes” Read more
READ MORE“Too much at stake in the EU pharma strategy to […]
Read more